Cargando…
COVID-19 and sickle cell disease in Bahrain
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is caused by a newly identified strain of the coronavirus family that has been shown to affect the hemoglobin beta chain, the same chain that has sickle cell disease (SCD) mutation. This study was undertaken to see if COVID-19 infection increased dis...
Autores principales: | AbdulRahman, Abdulkarim, AlAli, Salman, Yaghi, Omar, Shabaan, Mohammed, Otoom, Sameer, Atkin, Stephen L., AlQahtani, Manaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833176/ https://www.ncbi.nlm.nih.gov/pubmed/32980556 http://dx.doi.org/10.1016/j.ijid.2020.09.1433 |
Ejemplares similares
-
Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals
por: Kumar, Nitya, et al.
Publicado: (2021) -
The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects
por: Al-Qahtani, Manaf, et al.
Publicado: (2021) -
Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021) -
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2021) -
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)